Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
β Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds
Latest in Oncology/Hematology
New standard of care for patients in first remission?
Increased factor VIII levels to mild or moderate range, with annualized bleeding rate of zero
Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more
Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
Treatment tied to fewer vaso-occlusive pain events, hospitalizations versus placebo
AMPLIFY trial paves the way for FDA approval of acalabrutinib plus venetoclax
Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive
Complete responses seen in 43% of patients in expansion cohort of EPCORE CLL-1 study
Rilzabrutinib specifically designed to reduce platelet-targeting autoantibodies
Two-thirds of phase II patients had a complete response at 12 weeks of treatment
High-fiber diets tied to improved outcomes in stem-cell transplants, slowing myeloma precursors
Also in TTHealthWatch: U.S. drug prices under Medicare's price negotiation system
Cytokine release syndrome developed in all patients, including grade 3/4 events in nearly half
Blinatumomab consolidation reduced risk of relapse by 61% versus chemotherapy alone
Drug may potentially "transform" approach to upfront treatment, investigator says
Industry witness warns of unintended consequences of blanket bans
Overall cancer detection rate was about 43% higher versus women who chose not to participate
News, features, and commentary about cancer-related issues
